Lung-Function Response To Tiotropium plus Olodaterol In Patients With COPD With β-Agonist Reversibility

被引：0
|
作者：
Tashkin, D. P. [1 ]
Ferguson, G. T. [2 ]
Clerisme-Beaty, E. [3 ]
Vob, F. [4 ]
Buhl, R. [5 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Pulm Res Inst Southeast Michigan, Farmington Hills, MI USA
[3] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA
[4] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[5] Mainz Univ Hosp, Dept Pulm, Mainz, Germany
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6808
引用
收藏
页数：2
相关论文
共 50 条
  • [1] LUNG FUNCTION WITH TIOTROPIUM PLUS OLODATEROL IN EAST ASIAN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    Buhl, Roland
    Joens, Olaf
    Zhao, Yihua
    Ichinose, Masakazu
    RESPIROLOGY, 2015, 20 : 51 - 51
  • [2] LUNG FUNCTION WITH TIOTROPIUM PLUS OLODATEROL IN EAST ASIAN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    Bai, Chunxue
    Buhl, Roland
    Lee, Sang Haak
    Lee, Kwan Ho
    Joens, Olaf
    Zhao, Yihua
    Ichinose, Masakazu
    RESPIROLOGY, 2015, 20 : 53 - 53
  • [3] Lung Function Response With Tiotropium plus Olodaterol Maintenance Treatment in Patients With COPD in the TONADO and OTEMTO Studies: A Subgroup Analysis by Age
    Ferguson, Gary
    Clerisme-Beaty, Emmanuelle
    Groenke, Lars
    Voss, Florian
    Karpel, Jill
    CHEST, 2015, 148 (04)
  • [4] Efficacy And Safety Of Tiotropium plus Olodaterol In Patients With COPD By Ats Category
    Maltais, F.
    Pizzichini, E.
    Gronke, L.
    Vob, F.
    Derom, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [5] Tiotropium plus olodaterol provides significant lung-function benefits compared to fluticasone plus salmeterol regardless of prior bronchodilator use
    Derom, Eric
    Beeh, Kai-Michael
    Echave-Sustaeta, Jose
    Gronke, Lars
    Zhai, Dongmei
    Bjermer, Leif
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [6] Tiotropium plus olodaterol in patients with moderate to severe COPD with chronic bronchitis and/or emphysema
    Buhl, Roland
    Derom, Eric
    Bjermer, Leif
    Gronke, Lars
    Voss, Florian
    Flezar, Matjaz
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [7] The Effect of Tiotropium/Olodaterol versus Salmeterol/Fluticasone on Left Ventricular Function and Lung Hyperinflation in Patients with COPD
    Herth, F. J.
    Hohlfeld, J. M.
    Haas, J.
    de la Hoz, A.
    Jin, X.
    Kreitner, K.
    Vogelmeier, C. F.
    Vogel-Claussen, J.
    Watz, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [8] Characteristics of Patients With and Without COPD Exacerbations During the Tiotropium plus Olodaterol TONADO Studies
    Abrahams, Roger
    Bjermer, Leif
    Ferguson, Gary
    Pizzichini, Emilio
    Voss, Florian
    Tafur, Carlos
    Buhl, Roland
    CHEST, 2016, 150 (04) : 858A - 858A
  • [9] Effect Of Tiotropium plus Olodaterol Therapy On COPD Exacerbations In The Tonado® Studies
    Derom, E.
    Flezar, M.
    Gronke, L.
    Vob, F.
    Buhl, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [10] Benefits Of Tiotropium plus Olodaterol Over Tiotropium At Delaying Clinically Significant Events In Patients With COPD Classified As Gold B
    Buhl, R.
    McGarvey, L.
    Korn, S.
    Ferguson, G. T.
    Gronke, L.
    Hallmann, C.
    Vob, F.
    Rabe, K. F.
    Maltais, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
12345